Bank of Nova Scotia’s Charles River Laboratories CRL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.42M Buy
19,844
+13,185
+198% +$2.44M 0.01% 657
2025
Q4
$1.33M Buy
6,659
+1,415
+27% +$257K ﹤0.01% 841
2025
Q3
$820K Sell
5,244
-198,074
-97% -$31.5M ﹤0.01% 818
2025
Q2
$30.8M Buy
203,318
+201,463
+10,861% +$26.9M 0.06% 203
2025
Q1
$279K Sell
1,855
-3,156
-63% -$529K ﹤0.01% 901
2024
Q4
$925K Buy
5,011
+232
+5% +$44.7K ﹤0.01% 790
2024
Q3
$941K Buy
4,779
+1,744
+57% +$362K ﹤0.01% 771
2024
Q2
$627K Sell
3,035
-2,060
-40% -$467K ﹤0.01% 823
2024
Q1
$1.38M Buy
5,095
+727
+17% +$174K ﹤0.01% 731
2023
Q4
$1.03M Buy
4,368
+1,734
+66% +$341K ﹤0.01% 772
2023
Q3
$516K Buy
2,634
+513
+24% +$105K ﹤0.01% 793
2023
Q2
$446K Sell
2,121
-1,402
-40% -$279K ﹤0.01% 839
2023
Q1
$711K Sell
3,523
-624
-15% -$141K ﹤0.01% 781
2022
Q4
$904K Sell
4,147
-40
-1% -$8.73K ﹤0.01% 826
2022
Q3
$824K Buy
4,187
+2
+0% +$432 ﹤0.01% 836
2022
Q2
$896K Sell
4,185
-36,991
-90% -$9.04M ﹤0.01% 872
2022
Q1
$11.7M Buy
41,176
+31,585
+329% +$9.74M 0.02% 413
2021
Q4
$3.62M Buy
9,591
+1,188
+14% +$462K 0.01% 782
2021
Q3
$3.47M Buy
8,403
+703
+9% +$292K 0.01% 724
2021
Q2
$2.85M Buy
+7,700
New +$2.57M 0.01% 725
2021
Q1
Sell
-44,189
Closed -$11M 1057
2020
Q4
$11M Buy
44,189
+4,216
+11% +$1M 0.02% 361
2020
Q3
$9.05M Sell
39,973
-29,795
-43% -$6.18M 0.03% 377
2020
Q2
$12.2M Buy
69,768
+30,770
+79% +$4.91M 0.04% 273
2020
Q1
$4.92M Sell
38,998
-43,347
-53% -$6.5M 0.02% 428
2019
Q4
$12.6M Sell
82,345
-50,004
-38% -$6.92M 0.03% 353
2019
Q3
$17.5M Buy
132,349
+121,089
+1,075% +$16.2M 0.05% 285
2019
Q2
$1.6M Buy
11,260
+260
+2% +$35.3K 0.01% 647
2019
Q1
$1.6M Sell
11,000
-39,100
-78% -$5.14M 0.01% 663
2018
Q4
$5.67M Buy
+50,100
New +$6.27M 0.03% 378
2014
Q2
Sell
-145,000
Closed -$8.75M 569
2014
Q1
$8.75M Buy
+145,000
New +$8.45M 0.04% 164

Other funds holding CRL